Literature DB >> 22440596

Endovascular treatment of recurrent coiled aneurysms: assessment of complications and rebleeding during a decade in a single center.

J Sedat1, Y Chau, K Moubarak, J Vargas, M Lonjon.   

Abstract

Recurrence is the main drawback of aneurysmal coiling. Additional coiling must sometimes be considered in patients with reopened aneurysms and expose the patient to the risk of a new procedure. Our purpose was to assess the procedural complications of additional endovascular treatments in patients with previously coiled but recurrent aneurysms treated by two neurointerventionalists during a decade in a single center. Between 1999 and 2009, 637 intracranial aneurysms were coiled and had a clinical and angiographic follow-up at our institution. Following the first embolization, 44 aneurysms were retreated with coils and 11 were retreated a second time. Retreatment was decided when a recurrence showed at angiographic follow-up. Early retreatments, performed in the first month after an incomplete or failed initial coiling, were excluded. We retrospectively analysed the procedural complications, rebleeding, clinical and angiographic outcomes of the retreatments. No death or bleeding occurred in these 55 additional procedures. We had three periprocedural thromboembolic complications and the procedural permanent morbidity was 1.8%. Clinical and angiographic follow-ups ranged from six months to nine years (mean: 37 months, median: 36 months). Thirty-seven of the 44 retreated aneurysms (84%) showed a stable occlusion at follow-up. Seven showed a recurrence but were not retreated due to the stability of the packing. No rebleeding was observed during the follow-up period. Our results show that endovascular treatment of recurrent aneurysms is associated with a low procedural risk.

Entities:  

Mesh:

Year:  2012        PMID: 22440596      PMCID: PMC3312084          DOI: 10.1177/159101991201800102

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  39 in total

Review 1.  Treatment of intracranial aneurysms by embolization with coils: a systematic review.

Authors:  E H Brilstra; G J Rinkel; Y van der Graaf; W J van Rooij; A Algra
Journal:  Stroke       Date:  1999-02       Impact factor: 7.914

2.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

3.  Periprocedural morbidity and mortality associated with endovascular treatment of intracranial aneurysms.

Authors:  Hae-Kwan Park; Michael Horowitz; Charles Jungreis; Julie Genevro; Christopher Koebbe; Elad Levy; Amin Kassam
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

4.  Long-term angiographic follow-up of 169 intracranial berry aneurysms occluded with detachable coils.

Authors:  C Cognard; A Weill; L Spelle; M Piotin; L Castaings; A Rey; J Moret
Journal:  Radiology       Date:  1999-08       Impact factor: 11.105

5.  Five-year experience in using coil embolization for ruptured intracranial aneurysms: outcomes and incidence of late rebleeding.

Authors:  J V Byrne; M J Sohn; A J Molyneux; B Chir
Journal:  J Neurosurg       Date:  1999-04       Impact factor: 5.115

6.  Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals.

Authors:  S C Johnston; R A Dudley; D R Gress; L Ono
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

7.  Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis.

Authors:  T W Raaymakers; G J Rinkel; M Limburg; A Algra
Journal:  Stroke       Date:  1998-08       Impact factor: 7.914

8.  Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils.

Authors:  Jean Raymond; François Guilbert; Alain Weill; Stavros A Georganos; Louis Juravsky; Anick Lambert; Julie Lamoureux; Miguel Chagnon; Daniel Roy
Journal:  Stroke       Date:  2003-05-29       Impact factor: 7.914

9.  Guglielmi detachable coil embolization of cerebral aneurysms: 11 years' experience.

Authors:  Yuichi Murayama; Yih Lin Nien; Gary Duckwiler; Y Pierre Gobin; Reza Jahan; John Frazee; Neil Martin; Fernando Viñuela
Journal:  J Neurosurg       Date:  2003-05       Impact factor: 5.115

10.  Additional coiling of previously coiled cerebral aneurysms: clinical and angiographic results.

Authors:  Marjan J Slob; Menno Sluzewski; Willem Jan van Rooij; Gerwin Roks; Gabriël J E Rinkel
Journal:  AJNR Am J Neuroradiol       Date:  2004-09       Impact factor: 3.825

View more
  5 in total

Review 1.  Recurrence of endovascularly and microsurgically treated intracranial aneurysms-review of the putative role of aneurysm wall biology.

Authors:  Serge Marbacher; Mika Niemelä; Juha Hernesniemi; Juhana Frösén
Journal:  Neurosurg Rev       Date:  2017-08-17       Impact factor: 3.042

2.  Predictors of success following endovascular retreatment of intracranial aneurysms.

Authors:  Justin R Mascitelli; Eric K Oermann; J Mocco; Johanna T Fifi; Srinivasan Paramasivam; Christopher J Stapleton; Aman B Patel
Journal:  Interv Neuroradiol       Date:  2015-06-19       Impact factor: 1.610

3.  A Novel Flow Diverter (Tubridge) for the Treatment of Recurrent Aneurysms: A Single-Center Experience.

Authors:  Yongxin Zhang; Qing-Hai Huang; Yibin Fang; Pengfei Yang; Yi Xu; Bo Hong; Jianmin Liu
Journal:  Korean J Radiol       Date:  2017-07-17       Impact factor: 3.500

4.  Treatment of recurrent aneurysms using the Woven EndoBridge (WEB): anatomical and clinical results.

Authors:  Matthias Gawlitza; Sebastien Soize; Anne-Christine Januel; Cristian Mihalea; Georgios-Emmanouil Metaxas; Christophe Cognard; Laurent Pierot
Journal:  J Neurointerv Surg       Date:  2017-10-20       Impact factor: 5.836

5.  Treatment of experimental aneurysms with a GPX embolic agent prototype: preliminary angiographic and histological results.

Authors:  Frederik Fries; Toshiki Tomori; Walter J Schulz-Schaeffer; Joshua Jones; Umut Yilmaz; Michael Kettner; Andreas Simgen; Wolfgang Reith; Ruben Mühl-Benninghaus
Journal:  J Neurointerv Surg       Date:  2021-05-04       Impact factor: 5.836

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.